ArticleNaunyn-Schmiedeberg's archives of pharmacology2026
From network prediction to in vivo validation: luteolin attenuates cholestatic liver injury in association with PI3K/Akt/GSK-3β signalling modulation.
Yuxin Wu et al.PubMed ↗Publisher ↗
No numbers read from the abstract.